C B Saw1, K M Ayyangar, W Zhen
1Department of Radiation Oncology, University of Nebraska Medical Center, Omaha 68198-7521, USA. csaw@nhsnet.org
This study details the commissioning and quality assurance (QA) for linear accelerator multileaf collimator (MLC)-based intensity-modulated radiation therapy (IMRT). Rigorous QA ensures accurate dose delivery for advanced cancer treatments.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: